|
1
|
Ferrer RA, Wobus M, List C, et al:
Mesenchymal stromal cells from patients with myelodyplastic
syndrome display distinct functional alterations that are modulated
by lenalidomide. Haematologica. 98:1677–1685. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arndt K, Grinenko T, Mende N, et al: CD133
is a modifier of hematopoietic progenitor frequencies but is
dispensable for the maintenance of mouse hematopoietic stem cells.
Proc Natl Acad Sci USA. 110:5582–5587. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bai H, Xie YL, Gao YX, Cheng T and Wang
ZZ: The balance of positive and negative effects of TGF-β signaling
regulates the development of hematopoietic and endothelial
progenitors in human pluripotent stem cells. Stem Cells Dev.
22:2765–2776. 2013.
|
|
4
|
Itkin T, Kaufmann KB, Gur-Cohen S, Ludin A
and Lapidot T: Fibroblast growth factor signaling promotes
physiological bone remodeling and stem cell self-renewal. Curr Opin
Hematol. 20:237–244. 2013.PubMed/NCBI
|
|
5
|
Mizer JC, Ichim TE, Alexandrescu DT, et
al: Exogenous endothelial cells as accelerators of hematopoietic
reconstitution. J Transl Med. 10:2312012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao W, Wang Y, Wang D, et al: TGF-beta
expression by allogeneic bone marrow stromal cells ameliorates
diabetes in NOD mice through modulating the distribution of CD4+ T
cell subsets. Cell Immunol. 253:23–30. 2008.PubMed/NCBI
|
|
7
|
Boroujeni MB, Salehnia M, Valojerdi MR,
Mowla SJ, Forouzandeh M and Hajizadeh E: Comparison of gene
expression profiles in erythroid-like cells derived from mouse
embryonic stem cells differentiated in simple and co-culture
systems. Am J Hematol. 83:109–115. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Angelopoulou M, Novelli E, Grove JE, et
al: Cotransplantation of human mesenchymal stem cells enhances
human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp
Hematol. 31:413–420. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qiu H, Fujimori Y, Kai S, Fujibayashi Y,
Nishioka K and Hara H: Establishment of mouse embryonic fibroblast
cell lines that promote ex vivo expanssion of human cord blood
CD34+ hematopoietic progenitors. J Hematother Stem Cell Res.
12:39–46. 2003.PubMed/NCBI
|
|
10
|
Campana D, Coustan-Smith E, Kumagai MA and
Manabe A: Growth requirements of normal and leukemic human B cell
progenitors. Leuk Lymphoma. 13:359–371. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fischer D, Poncin J, Dunet R, Dry J and
Thomas M: Evaluation of the results of treatment of Graves’ disease
by synthetic antithyroid drugs. Sem Hop. 53:1843–1849. 1977.(In
French).
|
|
12
|
Junik R, Lacka K, Sowiński J,
Horst-Sikorska W and Gembicki M: Anti-thyroid antibodies and
thyroglobulin in the serum of patients with hyperthyroidism treated
with methylthiouracil. Pol Tyg Lek. 42:1120–1123. 1987.(In
Polish).
|
|
13
|
Léger J, Gelwane G, Kaguelidou F, Benmerad
M and Alberti C; French Childhood Graves’ Disease Study Group.
Positive impact of long-term antithyroid drug treatment on the
outcome of children with Graves’ disease: national long-term cohort
study. J Clin Endocrinol Metab. 97:110–119. 2012.
|
|
14
|
Oliveira PH, Boura JS, Abecasis MM, Gimble
JM, da Silva CL and Cabral JM: Impact of hypoxia and long-term
cultivation on the genomic stability and mitochondrial performance
of ex vivo expanded human stem/stromal cells. Stem Cell Res.
9:225–236. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Havlas V, Kos P, Jendelová P, Lesný P, Trč
T and Syková E: Comparison of chondrogenic differentiation of
adipose tissue-derived mesenchymal stem cells with cultured
chondrocytes and bone marrow mesenchymal stem cells. Acta Chir
Orthop Traumatol Cech. 78:138–144. 2011.(In Czech).
|
|
16
|
Colter DC, Sekiya I and Prockop DJ:
Identification of a subpopulation of rapidly self-renewing and
multipotential adult stem cells in colonies of human marrow stromal
cells. Proc Natl Acad Sci USA. 98:7841–7845. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kuo YC, Yeh CF and Yang JT:
Differentiation of bone marrow stromal cells in
poly(lactide-co-glycolide)/chitosan scaffolds. Biomaterials.
30:6604–6613. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dezawa M, Kanno H, Hoshino M, et al:
Specific induction of neuronal cells from bone marrow stromal cells
and application for autologous transplantation. J Clin Invest.
113:1701–1710. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chung YC, Ma MC, Huang BY, Chiang HS and
Chou SH: Protection of bone marrow-derived CD45+/CD34−/lin-stromal
cells with immunosuppressant activity against ischemia/reperfusion
injury in rats. Chin J Physiol. 54:169–182. 2011.
|
|
20
|
Mosmann T: Rapid colorimetric asay for
cellular growth and survival: application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fromigué O, Kheddoumi N, Lomri A, Marie PJ
and Body JJ: Breast cancer cells release factors that induced
apoptosis in human bone morrow stromal cells. J Bone Miner Res.
16:1600–1610. 2001.PubMed/NCBI
|
|
22
|
Basak P, Chatterjee S, Das P, et al:
Leukemic stromal hematopoietic microenvironment negatively
regulates the normal hematopoiesis in mouse model of leukemia. Chin
J Cancer. 29:969–979. 2010. View Article : Google Scholar
|
|
23
|
Glennie S, Soeiro I, Dyson PJ, Lam EW and
Dazzi F: Bone marrow mesenchymal stem cells induce division arrest
anergy of activated T cells. Blood. 105:2821–2827. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Palii CG, Pasha R and Brand M:
Lentiviral-mediated knockdown during ex vivo erythropoiesis of
human hematopoietic stem cells. J Vis Exp. 16:28132011.PubMed/NCBI
|
